- Home
- SCCO vs GSK Comparison
SCCO vs GSK Comparison
Compare SCCO & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCCO
- GSK
- Stock Information
- Founded
- SCCO 1952
- GSK 1715
- Country
- SCCO United States
- GSK United Kingdom
- Employees
- SCCO N/A
- GSK N/A
- Industry
- SCCO Metal Mining
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- SCCO Basic Materials
- GSK Health Care
- Exchange
- SCCO Nasdaq
- GSK Nasdaq
- Market Cap
- SCCO 92.9B
- GSK 79.8B
- IPO Year
- SCCO N/A
- GSK N/A
- Fundamental
- Price
- SCCO $111.97
- GSK $38.97
- Analyst Decision
- SCCO Sell
- GSK Buy
- Analyst Count
- SCCO 7
- GSK 5
- Target Price
- SCCO $91.42
- GSK $48.00
- AVG Volume (30 Days)
- SCCO 1.1M
- GSK 5.1M
- Earning Date
- SCCO 10-30-2024
- GSK 10-30-2024
- Dividend Yield
- SCCO 2.13%
- GSK 4.03%
- EPS Growth
- SCCO N/A
- GSK N/A
- EPS
- SCCO 3.51
- GSK 1.24
- Revenue
- SCCO $10,519,300,000.00
- GSK $39,741,175,591.00
- Revenue This Year
- SCCO $19.15
- GSK $7.41
- Revenue Next Year
- SCCO $4.34
- GSK $5.65
- P/E Ratio
- SCCO $31.87
- GSK $15.58
- Revenue Growth
- SCCO 4.44
- GSK 7.20
- 52 Week Low
- SCCO $68.59
- GSK $33.67
- 52 Week High
- SCCO $129.14
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- SCCO 50.83
- GSK 41.38
- Support Level
- SCCO $110.80
- GSK $38.82
- Resistance Level
- SCCO $118.46
- GSK $39.40
- Average True Range (ATR)
- SCCO 2.75
- GSK 0.80
- MACD
- SCCO -0.85
- GSK 0.01
- Stochastic Oscillator
- SCCO 18.46
- GSK 29.13
About SCCO Southern Copper Corporation
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.